TNF and neoplasm: While treatment with AZD4573 led to modest prolongation of survival in an ibrutinib-resistant MCL PDX mouse model, accompanied by downregulation of TNF/NF-B and mTORC1 signaling pathways in murine splenocytes, OxPhos was upregulated suggesting tumor metabolic reprogramming.